Hourly refreshWed, Jul 22, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

3,186 press releases indexed under healthcare.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Finance · AI

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the ...

(PR-inside.com) VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation HOUSTON, TX / ACCESS Newswire / July 14, 2026 / VSee Health, Inc. (Nasdaq:VSEE) ("VSee" or the "Company"), a leading provider of enterprise telehealth solutions for hospitals and health systems, today shared its strategic initiatives and perspective on the role of artificial intelligence in healthcare and why enterprise telehealth platforms are well positioned to serve as the infrastructure layer for that transformation. "We believe healthcare is entering a new technology cycle in which artificial intelligence becomes an operating layer, rather than simply another application," said Dr. Imoigele Aisiku, Chairman and ..

Jul 14 · 13:01PR-Inside
AI · SaaS

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations

VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation

Jul 14 · 13:00Newswire.com
AI · Healthcare

Clinicians Have Become Healthcare's Human Middleware, New Vendor-Agnostic ...

(PR-inside.com) EHR fragmentation, payer demands and unproven AI efficiencies are adding hidden labor across clinical workflows CHICAGO, IL / ACCESS Newswire / July 14, 2026 / Black Book Research today releasedThe Work That Didn't Disappear: The Black Book Clinician Reality Index , a nine-month national study finding that healthcare technology is frequently shifting work to clinicians rather than eliminating it. The vendor-agnostic survey of 1,919 clinicians found that 80.7% use at least one workaround every day, while 65.2% lose 30 minutes or more per day or shift to avoidable digital work. Clinicians reported repeatedly re-entering information, reconciling external records, monitoring disconnected queues, checking payer ..

Jul 14 · 12:55PR-Inside
AI · Healthcare

Clinicians Have Become Healthcare's Human Middleware, New Vendor-Agnostic Report Finds from Black Book Research

EHR fragmentation, payer demands and unproven AI efficiencies are adding hidden labor across clinical workflows

Jul 14 · 12:55Newswire.com
Finance · AI

Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform

Access to AMD Developer Cloud credits, AI development tools and technical resources to support next-generation enterprise AI agents Access to AMD Developer Cloud credits, AI development tools and technical resources to support next-generation enterprise AI agents

Jul 14 · 12:55GlobeNewswire
Healthcare

New Research Reveals Major Communication Gap Between Health Plans and New Mothers

More than half of new mothers don't fully understand their care plans, while health plan leaders rank member engagement and navigation as a top maternal health priority BALTIMORE, July 14, 2026 /PRNewswire/ -- More communication doesn't necessarily mean better communication for pregnant...

Jul 14 · 12:50PR Newswire
Healthcare

MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia

TORONTO, July 14, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specializing in precision-based cannabinoids, today announced positive results from the Phase II LiBBY (Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol) clinical trial evaluating the Company’s proprietary oral cannabinoid formulation for the treatment of agitation in patients with advanced dementia. The results were presented by the LiBBY team at AAIC in London, United Kingdom on July 14, 2026.

Jul 14 · 12:35GlobeNewswire
Finance · Healthcare

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

Sponsors educational summit of leading pediatric AKI health care experts

Jul 14 · 12:34GlobeNewswire
Healthcare

Vitalist to Participate in a Fireside Chat at the Health, Wellness & Longevity Conference Presented by Maxim Group

CALGARY, Alberta, July 14, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. ( TSX-V: VITA.V ; OTCQB: VTLSF ) (" Vitalist "), is pleased to announce that Company CEO Kalvie Legat and CSO Charles Herman will participate in a virtual fireside chat at the Health, Wellness & Longevity Conference presented by Maxim Group on Wednesday, July 22.

Jul 14 · 12:30GlobeNewswire
AI · Healthcare

Medical Care Technologies Inc. (OTC PINK:MDCE) Snapshot Recipes AI ...

(PR-inside.com) First 24 Hours of Performance Ads Match Lifetime Downloads - Positioning for Accelerated Consumer Growth MESA, AZ / ACCESS Newswire / July 14, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a major evolution for its popular AI-powered mobile app, Snapshot Recipes, introducing a new freemium model designed to dramatically expand user access while accelerating growth. Download Snapshot Recipes for free now: https://snapshotrecipes.app/get/ Snapshot Recipes empowers users to create instant, personalized recipes by simply snapping a photo of their groceries, open fridge, ingredients, a saved meal image, or even a screenshot from social media. The app instantly delivers chef-inspired recipes with ..

Jul 14 · 12:17PR-Inside
AI · Healthcare

Medical Care Technologies Inc. (OTC PINK:MDCE) Snapshot Recipes AI Powered Mobile App Hits New Milestone with Freemium Model and Strong Marketing Results

First 24 Hours of Performance Ads Match Lifetime Downloads - Positioning for Accelerated Consumer Growth

Jul 14 · 12:17Newswire.com
Finance · Healthcare

Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding ...

(PR-inside.com) Funds Advance FDA-Designated Breakthrough Therapy First-in-Class Opioid with Oral Overdose-Protection SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics engineered to minimize abuse and overdose risk, today announced receipt of a Notice of Award for $5.3 million from the National Institutes on Drug Abuse (NIDA)1 to support the development of its novel MPAR® (Multi-Pill Abuse Resistance) overdose-protection technology, and the lead agent, PF614-MPAR. This marks the third consecutive year of NIDA funding under this award, reflecting sustained institutional confidence in ..

Jul 14 · 12:01PR-Inside
← Prev123266Next →